The OCR is a driving force in the development and support of clinical trials. Our office identifies and monitors enterprise-wide metrics describing the level of ongoing industry-sponsored clinical trial activities.
To enhance our ability to develop performance improvements that increase planned subject accrual into clinical studies – we are measuring and reporting to IU and IU Health senior leadership the accrual ratio for all studies currently open to accrual.
Data is collected from our OnCore (clinical research management system) database at the individual study level and reported in aggregate at a departmental/division level and at the enterprise level.
For more information regarding the accrual metric, please review the Accrual Ratio FAQ.